Clinician reviewing notes in a hospital corridor

Specialty & Hard-to-Reach Audiences

The audiences standard panels cannot fill

Healthcare professionals, IT and C-suite decision-makers, rare disease patients and low-incidence segments, reached through specialist sourcing.

<1%

Incidence routinely worked

3-stage

Verification

500+

Specialist studies run

Specialty & Hard-to-Reach Audiences

Low-incidence audiences are not a harder version of ordinary sampling — they are a different job. Volume does not help when the target is one in two hundred and the panel has never profiled for it.

We reach these audiences through association networks, professional communities, referral chains and direct outreach, with verification at each stage before anyone enters your data.

  • Verified healthcare and clinical professionals
  • Senior B2B and C-suite decision-makers
  • Rare disease and low-incidence patient groups
  • Multi-stage verification before entry to the study
Clinician reviewing notes in a hospital corridor

Our capabilities

What our specialty & hard-to-reach audiences service covers

We own the workflow end to end, which is what makes a single point of accountability possible rather than just claimable.

Healthcare professionals

Physicians by specialty, nurses, pharmacists and allied health professionals, with licence and practice verification and honorarium reporting where it is required.

Senior B2B decision-makers

C-suite, IT, procurement, finance and HR leaders, verified against company size, sector code and decision authority rather than a self-reported job title.

Patient and caregiver populations

Condition-specific patient groups including rare disease, reached through advocacy networks and clinical referral with ethical protocols agreed in advance.

Referral and snowball sourcing

Structured referral chains for populations too small to sample directly, with bias tracked and reported rather than glossed over.

Multi-stage verification

Screener, documentary and behavioural verification applied in sequence. Each stage removes a different kind of false positive.

Honest feasibility

If an audience cannot be delivered at the sample size, timeline or price in the brief, you hear it before the project starts, with what is achievable instead.

Included in every project

Standard on every engagement, not an upgrade

The same six things are included whichever service a project starts from. They are the reason our quotes look like they do.

Screening design

We work through your screener with you before fieldwork opens — quota alignment, incidence estimation and disqualification logic, agreed in writing.

Multi-source recruitment

Our own panel across core markets plus a vetted partner network reaching 35+ countries. No single source carries a project; diversity of sourcing is what keeps the sample honest.

Layered quality assurance

Screener validation, digital fingerprinting against duplicates, automated response scoring, analyst review and post-field back-checking where the study calls for it.

Confirmation and scheduling

Reminder workflows for qualitative work, with standby replacements held as standard so a no-show does not become a gap in your data.

Incidence reporting

Funnel data and incidence rates before and during fieldwork, so a feasibility problem reaches you while there is still time to act on it.

A named project manager

One person accountable from brief to delivery, with daily field updates — not a shared inbox and not a ticket queue.

FAQ

Frequently asked questions — specialty & hard-to-reach audiences

How do you verify healthcare professionals?
Registration or licence number checks against public registers where available, practice verification, and screener consistency checks across the recruitment and the survey itself.
What is the lowest incidence you have worked with?
Well below one percent. At that level the honest answer is usually a longer timeline and a higher cost per complete, and we quote it that way rather than promising the impossible.
Can you reach rare disease patients?
Yes, through advocacy organisations, clinical networks and patient communities, with ethical review and consent protocols agreed before any outreach begins.
What if the audience turns out not to be feasible?
You are told during feasibility, not during fieldwork, and we propose the nearest achievable definition so the study can proceed on a sound basis.

Send us the brief. We will tell you what is feasible.

Feasibility, incidence and costs within one working day — including the markets where your target, as written, is not achievable.